Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Gas Station Outages Soar

The current gas crisis has left many Southern states without…
Read more

Jen Psaki: Israelis/Palestinians Must Solve Conflict Locally

According to the White House Press Secretary, Jen Psaki,…
Read more

Chaplain Reported for LGBT Sermon

A chaplain was reported to an anti-terrorist program after…
Read more